百奥赛图-B(02315)获调入港股通证券名单

Core Viewpoint - The company Biocytogen-B (02315) has announced that its shares listed on the Hong Kong Stock Exchange will be included in the Stock Connect program, effective December 24, 2025, allowing eligible investors from mainland China to invest directly in the company's H-shares [1] Group 1 - The inclusion of the company's H-shares in the Stock Connect program will expand its investor base [1] - This move is expected to enhance the trading liquidity of the company's H-shares [1]